Header

UZH-Logo

Maintenance Infos

Chronic granulomatous disease: recent advances in pathophysiology and treatment


Seger, R A (2010). Chronic granulomatous disease: recent advances in pathophysiology and treatment. The Netherlands Journal of Medicine, 68(11):334-340.

Abstract

Chronic granulomatous disease (CGD) was characterised half a century ago as a primary immunodeficiency disorder of phagocytic cells resulting in failure to kill a specific spectrum of bacteria and fungi and in concomitant hyperinflammation with widespread tissue granuloma formation. CGD now comprises five genetic defects, each impairing one of five essential subunits of the phagocyte NADPH oxidase generating reactive oxygen species. In the past few years CGD has lead to a new understanding of the importance of phagocyte oxygen metabolism for intra- and extracellular host defence and for resolution of the concomitant inflammatory process. In a not too distant future, this may help to tailor novel pharmacological and cellular interventions to the requirements of individual patients. This review covers recent advances in the pathophysiology of CGD and outlines today's clinical presentation as well as the basic principles for treatment of this relatively rare genetic disease. 'Fatal' granulomatous disease 50 years later has become a chronic inflammatory disorder with a median survival of 30 years and is of interest to both paediatricians and internists.

Abstract

Chronic granulomatous disease (CGD) was characterised half a century ago as a primary immunodeficiency disorder of phagocytic cells resulting in failure to kill a specific spectrum of bacteria and fungi and in concomitant hyperinflammation with widespread tissue granuloma formation. CGD now comprises five genetic defects, each impairing one of five essential subunits of the phagocyte NADPH oxidase generating reactive oxygen species. In the past few years CGD has lead to a new understanding of the importance of phagocyte oxygen metabolism for intra- and extracellular host defence and for resolution of the concomitant inflammatory process. In a not too distant future, this may help to tailor novel pharmacological and cellular interventions to the requirements of individual patients. This review covers recent advances in the pathophysiology of CGD and outlines today's clinical presentation as well as the basic principles for treatment of this relatively rare genetic disease. 'Fatal' granulomatous disease 50 years later has become a chronic inflammatory disorder with a median survival of 30 years and is of interest to both paediatricians and internists.

Statistics

Citations

Dimensions.ai Metrics
41 citations in Web of Science®
48 citations in Scopus®
77 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

2 downloads since deposited on 09 Feb 2011
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2010
Deposited On:09 Feb 2011 18:34
Last Modified:16 Mar 2018 08:44
Publisher:Van Zuiden Communications
ISSN:0300-2977
OA Status:Closed
Free access at:Official URL. An embargo period may apply.
Official URL:http://www.zuidencomm.nl/njm/getpdf.php?id=10000642
Related URLs:http://www.zuidencomm.nl/magazines/index.php?i=2 (Publisher)
PubMed ID:21116026

Download